4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0001548538-20-000027
10% owner bought 47,619 shares at $21.00 ($999,999)
- 10% owner acquired 2,174,179 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Presidio Management Group XII, L.L.C. · 10% owner
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-08 | Conversion : show line 1 in the form | +1,779,969 | 1,779,969 | I | ||
| 2020-12-08 | Conversion : show line 2 in the form | +289,198 | 2,069,167 | I | ||
| 2020-12-08 | Conversion : show line 3 in the form | +90,335 | 90,335 | I | ||
| 2020-12-08 | Conversion : show line 4 in the form | +14,677 | 105,012 | I | ||
| 2020-12-08 | Purchase : show line 5 in the form | +47,619 | $21.00 | $999,999 | 47,619 | I |
| Open-market purchases · 47,619 sh · avg $21.00 · $999,999 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2020-12-08 | Conversion : show line 6 in the form Preferred Series B Stock | −6,609,027 | 1,779,969 | 0 | I |
| 2020-12-08 | Conversion : show line 7 in the form Preferred Series B Stock | −335,417 | 90,335 | 0 | I |
| 2020-12-08 | Conversion : show line 8 in the form Preferred Series C Stock | −1,073,793 | 289,198 | 0 | I |
| 2020-12-08 | Conversion : show line 9 in the form Preferred Series C Stock | −54,496 | 14,677 | 0 | I |
Loading xslF345X03/edgar.xml…